Navigating billing oncology —especially for infusions and injectable drugs—can feel like walking a tightrope. One misstep in coding, documentation, or prior authorizations can lead to claim denials, compliance headaches, and lost revenue.

With 20% of oncology claims denied due to avoidable errors, getting it right isn’t just important—it’s critical for keeping your practice healthy. Let’s break down the common hurdles and how to leap over them.

The Big 6 Billing Oncology  Mistakes (and How to Dodge Them)

• “Wait, How Many Units?” – Miscalculating Drug Dosages

Every drug has its own billing code (HCPCS) with strict unit rules. Miscounting units is like pouring medicine into the wrong syringe—15% of errors start here. Double-check that the patient’s chart matches what you bill.

• Modifier Mayhem

Missing or misusing modifiers (like -JW for drug waste or -59 for separate procedures) is a fast track to denials. These tiny details matter—12% of denials stem from modifier mix-ups. Think of them as secret handshakes with payers; use the right ones!

• The Prior Auth Black Hole

Skipping prior authorization? That’s like showing up to a concert without a ticket. 30% of denials happen because approvals are missing. Always verify payer rules before treatment—your revenue cycle will thank you.

• “Prove It’s Necessary” – Incomplete Documentation

Payers demand proof that treatments are medically needed. Unclear records? 22% of denials come from shaky documentation. Spell out the why behind every chemo order.

• Insurance Tag-Teaming Gone Wrong

Many patients have dual coverage. Messy coordination of benefits (COB) delays payments and frustrates everyone. 18% of billing snags are COB-related. Verify coverage early—and often.

• The NDC Number Game

For injectables, missing or wrong National Drug Codes (NDCs) can sink claims. 10% of rejections trace back to NDC slip-ups. Match the code on the claim to the vial in your hand.

How to Stop Leaving Money on the Table

Partnering with oncology billing and coding experts can turn chaos into calm. Here’s what they bring:

• Coding Pros: No more guessing CPT or HCPCS codes—they’ll nail them.
• Claim “Detectives”: Scrubbing claims pre-submission cuts denials by spotting errors early.
• Prior Auth Wizards: They handle approvals so you don’t face delays.
• Audit Shields: Regular compliance checks keep you off payers’ radars.
• Insurance Whisperers: They untangle COB knots so payments flow smoothly.

FAQs

Q: Why is billing oncology so tricky?

A: Between ever-changing codes, prior auth hurdles, and payer hoops, it’s a maze. 17% of claims are denied for small errors—experts help you dodge them.

Q: How do I bill drugs correctly?

A: Track units like a hawk, use modifiers wisely, and always confirm coverage first. Better yet, let specialists handle the heavy lifting.

Q: What if a claim gets denied?

A: Don’t panic! Fix the error, add missing info, and appeal. 65% of appeals win with proper backup.

Q: Can billing services really boost revenue?

A: Absolutely. Clinics using experts see 20–30% faster payments and fewer denials. It’s like hiring a co-pilot for your revenue cycle.

Q: Which modifiers matter most?

A: -JW (wasted drugs), -59 (separate procedures), and –25 (extra E/M visits). Use them right, and denials drop by 15%.

The Bottom Line

Oncology billing doesn’t have to be a nightmare. By sidestepping common errors and teaming up with billing pros, you can slash denials, stay compliant, and focus on what matters—your patients.

Are you ready to stop losing revenue to billing errors?

 Let’s chat about making your claims bulletproof.

Maximize reimbursements. Minimize stress. Every claim counts.

The post Billing Oncology Infusions and Injectable Drugs: Common Errors to Avoid appeared first on Medical Billing and RCM Blogs.

Medical Billers and Coders has been assisting oncology practices for over two decades, helping them navigate these challenges. Based on our experience, here are five key signs that it’s time to switch to a more effective billing partner.

1. Constant Claim Denials and Delays

Why Denials Are a Major Concern?

Claim denials are more than just a nuisance—they directly impact your revenue. According to the Medical Group Management Association (MGMA), the average denial rate for medical claims is between 5% and 10%, but oncology practices often face higher rates due to the complexity of treatments. If your billing company isn’t proactively addressing denials, your practice could be losing thousands of dollars annually.

Common Reasons for Claim Denials in Oncology Billing

• Inaccurate coding (e.g., incorrect CPT or ICD-10 codes)
• Insufficient documentation to prove medical necessity
• Missed deadlines for claim submissions
• Errors in insurance verification

How Medical Billers and Coders Reduces Denials?

• Ensuring accurate coding and thorough documentation
• Implementing proactive denial management strategies
• Conducting timely follow-ups on unpaid claims
• Performing regular compliance audits

If your billing company isn’t resolving denials efficiently, it’s a clear sign of inefficiency that could jeopardize your practice’s financial health.

2. Lack of Compliance with Changing Regulations

Frequent Oncology Billing Compliance Issues

Oncology coding and billing is governed by strict regulations, including:

• Medicare and Medicaid rules
• HIPAA regulations
• Updates from the Centers for Medicare and Medicaid Services (CMS)

Risks of Non-Compliance

• Revenue loss due to rejected claims
• Legal penalties and fines (e.g., HIPAA violations can cost up to $50,000 per incident)
• Increased audits and scrutiny from payers

How Medical Billers and Coders Ensures Compliance?

• Regular staff training on the latest regulatory changes
• Accurate implementation of new billing guidelines
• Proactive measures to ensure adherence to compliance standards

If your billing company isn’t keeping up with regulatory changes, your practice could face significant financial and legal risks.

3. Poor Communication and Transparency

Importance of Open Communication

A billing company should provide:

• Clear explanations of billing reports
• Regular updates on claim statuses
• Responsive customer support

Signs of a Non-Responsive Billing Partner

• Delayed responses to queries
• Limited access to real-time billing data
• No clear plan to address claim issues

How Medical Billers and Coders Ensures Transparency?

• Assigning a dedicated account manager for each client
• Providing real-time access to financial reports
• Offering detailed performance analytics

If your billing company isn’t keeping you informed about your financial performance, it’s time to explore better options.

4. Inconsistent Revenue Cycle Performance

Identifying Revenue Leakage

A well-managed revenue cycle ensures steady cash flow. If your billing company is inefficient, you may experience:

• Frequent revenue shortfalls
• Increasing accounts receivable (AR) days (the average AR days for oncology practices should be under 40)
• High volumes of claim write-offs

Impact of an Inefficient Billing Company

• Lost revenue due to underpaid or rejected claims
• Unresolved claim disputes with payers
• Delays in insurance reimbursements

How Medical Billers and Coders Improves Revenue Cycle Performance?

• Optimizing claim submission processes
• Aggressive follow-ups on unpaid claims
• Using data-driven insights to enhance revenue collection

If your practice struggles with revenue fluctuations, it’s likely due to billing inefficiencies that need immediate attention.

5. Lack of Specialty-Specific Expertise

Why Oncology Billing Requires Specialized Knowledge?

Oncology treatments involve complex billing codes for chemotherapy, radiation therapy, and immunotherapy. Incorrect coding or documentation can lead to significant revenue losses.

Risks of Working with a Generalist Billing Company

• Incorrect bundling of chemotherapy and supportive care codes
• Failure to secure prior authorizations for high-cost treatments
• Mismanagement of reimbursement claims for biologic drugs

How Medical Billers and Coders Optimizes Oncology Billing?

• Accurate charge capture for all oncology procedures
• Specialized coding knowledge to maximize reimbursements
• Efficient pre-authorization and eligibility verification

If your billing company lacks oncology-specific expertise, your practice may not be achieving its full revenue potential.

How to Choose the Right Oncology Billing Company?

Key Factors to Consider

• Proven expertise in oncology billing
• Compliance with industry regulations
• Advanced technology for claims management

Questions to Ask Potential Billing Partners

• What is your strategy for reducing claim denials?
• How do you ensure compliance with the latest regulatory updates?
• Can you provide case studies demonstrating improved revenue cycles?

A billing company that cannot provide clear answers to these questions may not be the right fit for your oncology practice.

Frequently Asked Questions

1. How can I determine if my oncology billing company is underperforming?

Frequent claim denials, delayed reimbursements, and a lack of transparency are strong indicators.

2. What are the risks of staying with an inefficient billing company?

Revenue losses, regulatory penalties, and operational inefficiencies.

3. How often should I review the performance of my billing company?

Conduct quarterly reviews and a detailed annual audit.

4. Can a new billing company help recover lost revenue?

Yes, a specialized billing company can identify missed charges, resubmit denied claims, and optimize billing processes.

5. What should I look for in an oncology billing company?

Oncology-specific expertise, a strong track record, advanced technology, and a commitment to compliance.

6. Is outsourcing oncology billing better than managing it in-house?

Yes, outsourcing reduces billing errors, ensures compliance, and improves cash flow management.

Conclusion

If your oncology billing company is causing frequent claim denials, compliance risks, revenue fluctuations, or communication challenges, it’s time to consider a new partner. Medical Billers and Coders specializes in oncology billing and ensures your practice’s accuracy, compliance, and financial stability.

Don’t let inefficiencies hold your practice back—make the switch today to maximize your revenue potential.

The post 5 Signs It’s Time to Switch Your Oncology Billing Company appeared first on Medical Billing and RCM Blogs.

CPT Code 77338 Description

CPT code 77338 is used to report the delivery of radiation treatment using simple ports, which are defined as a single treatment area. This code is specific to radiation therapy services and is typically used in the context of external beam radiation treatment. It encompasses the delivery of therapeutic radiation to one or more separate treatment areas using simple radiation ports.

Coding Example

Let’s consider a hypothetical case to illustrate the use of this code. Suppose a patient is undergoing external beam radiation therapy to treat a tumor in their lung. During the treatment, the radiation oncologist utilizes a simple radiation port to deliver the radiation to the lung area only. In this scenario, CPT code 77338 would be appropriate to report the delivery of radiation therapy for this treatment session.

Coding Guidelines for CPT Code 77338

To ensure accurate coding and proper reimbursement, it is essential to adhere to the coding guidelines associated with this code. Here are some key guidelines to keep in mind:

• Treatment Area: CPT code 77338 should be used for reporting the delivery of radiation therapy to a single treatment area or multiple separate treatment areas using simple ports. If the treatment involves complex ports or multiple treatment areas within a single field, a different code may be more appropriate.
• Documentation: Accurate documentation is critical for proper coding. The medical record should clearly indicate the treatment area(s) and the use of simple ports for radiation therapy delivery.
• Modifier Usage: In some cases, modifiers may be necessary to provide additional information or clarify the circumstances. Always follow the specific instructions from payers regarding modifier usage with CPT code 77338.

Common Coding Mistakes

When coding with this code, it is important to be aware of potential coding mistakes that can lead to claim denials or underpayments. Some common errors to avoid include:

• Incorrect Number of Treatment Areas: Ensure that the number of treatment areas reported aligns with the documentation. Miscounting or omitting treatment areas can result in coding errors and improper reimbursement.
• Complex Port Usage: CPT code 77338 should only be used for simple port delivery. If complex ports are utilized, a different code should be selected.
• Inadequate Documentation: Insufficient documentation can lead to coding errors and claim denials. It is crucial to have clear documentation that supports the use of CPT code 77338, including details on the treatment areas and the use of simple ports.

Reimbursement Rates

Reimbursement rates for this code may vary depending on several factors, such as geographic location, payer policies, and the specific clinical setting. It is important to consult the appropriate payer fee schedule or seek guidance from the billing department to determine the specific reimbursement rates for this code.

Other Relevant Information

Here are a few additional points worth considering when working with CPT code 77338:

• Bundling and Unbundling: It is important to understand the bundling and unbundling rules related to radiation oncology codes. In some cases, additional codes may need to be reported along with CPT code 77338 to capture all the services provided during the treatment session.
• Documentation Requirements: Clear and detailed documentation is crucial for proper coding and reimbursement. The medical record should include information such as the treatment areas, simple port usage, dose calculation, treatment technique, and any other relevant details.
• Local Coverage Determinations (LCDs): Check for any applicable LCDs that may provide specific guidance or requirements for reporting CPT code 77338. LCDs are developed by Medicare Administrative Contractors (MACs) and can impact coding and reimbursement.

this code plays a significant role in radiation therapy coding and billing. It is essential to understand the code description, coding guidelines, and potential pitfalls associated with its usage. Accurate coding, supported by comprehensive documentation, ensures proper reimbursement and compliance.

Healthcare providers and coding professionals should stay informed about any updates or changes related to this code to maintain accurate and compliant coding practices in the dynamic field of radiation oncology.

About Medical Billers and Coders (MBC)

Medical Billers and Coders (MBC) is a renowned and trusted name in the healthcare industry, known for their expertise in radiation oncology billing. As a Leading Radiation Oncology Billing Company, MBC offers comprehensive billing and coding services tailored specifically to the unique needs of radiation oncology practices. With a team of highly skilled and certified medical coders and billers, MBC ensures accurate and timely submission of claims, meticulous coding compliance, and maximized reimbursement for radiation therapy services.

Our in-depth knowledge of CPT codes, modifiers, and documentation requirements, coupled with their commitment to staying updated with the latest industry regulations, makes MBC the go-to partner for Radiation Oncology Billing needs. For further information about our radiation oncology billing services, please reach out via email at info@medicalbillersandcoders.com or by calling 888-357-3226.

CPT® is a registered trademark of the American Medical Association

FAQs:

The post Understanding CPT Code 77338 appeared first on Medical Billing and RCM Blogs.

In this article, we will explore the radiation oncology codes for procedures like radiation treatment management; proton beam radiation treatment delivery; radiation hyperthermia treatment; clinical intracavitary radiation hyperthermia treatment; and clinical brachytherapy radiation treatment.

Radiation Oncology Codes

The CPT code range for radiation oncology is 77261-77799, which is maintained by American Medical Association. This code range is further divided into 10 sub categories, we explored the first five categories in the first part of this article, so let’s discuss the remaining radiation oncology codes:

6. Radiation Treatment Management (CPT Code Range 77427-77499)

Radiation Treatment Management is an essential aspect of radiation oncology, ensuring the safe and effective delivery of radiation therapy to patients. CPT codes within the range of 77427-77499 encompass a variety of services related to radiation treatment management.

Key CPT codes in this code range are as follows:

• 77427: Radiation treatment management, 5 treatments
• 77431: Radiation treatment management, 10 treatments
• 77432: Radiation treatment management, >10 treatments
• 77435: Special treatment procedure (e.g., total body irradiation, hemibody irradiation)
• 77470: Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks
• 77499: Unlisted procedure, radiation oncology

7. Proton Beam Radiation Treatment Delivery (CPT Code Range 77520-77525)

Proton beam radiation therapy is an advanced form of radiation treatment that utilizes proton beams instead of traditional photon beams. The corresponding CPT code range for proton beam radiation treatment delivery is 77520-77525.

It is important to note that the selection of the appropriate CPT code within the 77520-77525 range depends on several factors, including the complexity of the treatment plan, the number of treatment fields, the use of specialized techniques or equipment, and the level of integration with other treatment modalities.

In addition to the delivery of proton beam therapy itself, there are other associated services and procedures that may be coded separately. These may include treatment planning (CPT codes 77299 or 77370), simulation and localization procedures (CPT codes 77280-77295), and image guidance (CPT codes 77014 and 77417).

8. Radiation Hyperthermia Treatment (CPT Code Range 77600-77615)

Radiation hyperthermia treatment, also known as thermal therapy, is a specialized technique used in radiation oncology to enhance the effectiveness of radiation therapy by raising the temperature of the targeted tumor or cancerous tissue. The CPT code range 77600-77615 is dedicated to coding and billing for radiation hyperthermia treatments.

Let’s explore these codes in more detail. Some of the key CPT codes are as follows:

• 77600: Hyperthermia, superficial (e.g., microwave)
• 77605: Hyperthermia, external (including infrared)
• 77610: Hyperthermia, interstitial (including needle or catheter placement)
• 77615: Hyperthermia, intraoperative

Factors such as the type of heat source, treatment modality (external, superficial, interstitial, or intraoperative), and the extent of the treatment area should be taken into account when selecting the appropriate CPT code.

It is worth noting that these codes may have specific requirements and limitations set by insurance providers, Medicare, and other payers. Therefore, it is advisable to review the payer’s guidelines and policies to ensure compliance with their reimbursement requirements.

9. Clinical Intracavitary Radiation Hyperthermia Treatment (CPT Code 77620)

Clinical intracavitary radiation hyperthermia treatment (CPT code 77620) is a specialized procedure used in radiation oncology to treat certain types of cancer located within body cavities. It combines intracavitary radiation therapy with the application of heat, known as hyperthermia.

This treatment modality has shown promising results in improving treatment outcomes by enhancing the tumor’s response to radiation. Proper documentation and accurate reporting of this procedure are essential for appropriate billing and data collection purposes.

10. Clinical Brachytherapy Radiation Treatment (CPT Code Range 77750-77799)

Brachytherapy is a specialized form of radiation therapy that involves the placement of radioactive sources directly into or near the tumor. It allows for precise delivery of radiation to the affected area while minimizing exposure to surrounding healthy tissues.

The CPT code range 77750-77799 is dedicated to describing the different procedures and services associated with clinical brachytherapy radiation treatment.

The key CPT codes are as follows:

• 77750 – Remote afterloading high dose rate radionuclide brachytherapy
• 77761 – Interstitial or intracavitary brachytherapy, simple
• 77762 – Interstitial or intracavitary brachytherapy, complex

It is important to note that the specific CPT codes within the 77750-77799 range may vary based on the complexity and extent of the brachytherapy treatment. Some additional codes in this range cover specific types of brachytherapy procedures, such as intraoperative radiation therapy (IORT) or ocular brachytherapy.

We hope that this article and the first part of this article has given you an overview of radiation oncology codes. It is important to note that the information provided in this article serves as a general overview and does not substitute for the specific guidelines and regulations set forth by medical coding authorities.

Healthcare providers should consult the most up-to-date resources, such as official CPT coding guidelines and relevant billing regulations, for accurate and compliant coding and billing practices in radiation oncology. The American Medical Association (AMA) periodically releases updates to the CPT code set, including guidelines and instructions for proper code usage.

Regularly referring to these updates and consulting with coding experts can help ensure accurate coding and appropriate reimbursement for radiation oncology treatments.

About Medical Billers and Coders (MBC)

Medical Billers and Coders (MBC) is recognized as a leading radiation oncology billing company, providing comprehensive and specialized billing services tailored to the unique needs of radiation oncology practices.

With our deep expertise and extensive knowledge of the ever-evolving medical billing and coding landscape, MBC ensures accurate and efficient revenue cycle management for radiation oncology providers.

Our team of skilled professionals is well-versed in the intricacies of radiation oncology coding, including the specific CPT codes, modifiers, and documentation requirements.

By partnering with MBC, radiation oncology practices can streamline their billing processes, maximize reimbursement, and focus on delivering exceptional patient care. To know more about our radiation oncology billing services, email us at: info@medicalbillersandcoders.com or call us at: 888-357-3226.

CPT® is a registered trademark of the American Medical Association

FAQs:

The post An Overview of Radiation Oncology Codes – Part 2 appeared first on Medical Billing and RCM Blogs.

In this article, we will explore the radiation oncology codes for procedures like clinical treatment planning for radiation treatment; medical radiation physics, dosimetry, and treatment devices; stereotactic radiation treatment delivery; radiation treatment delivery; and neutron beam treatment delivery. We will discuss the rest of the radiation oncology codes in the second part of this article.

Radiation Oncology Codes

The CPT code range for radiation oncology is 77261-77799, which is maintained by American Medical Association. This code range is further divided into 10 subcategories, let’s explore the first five categories in detail:

1. Clinical Treatment Planning for Radiation Treatment (CPT Code Range 77261-77299)

Clinical treatment planning is a crucial step in radiation oncology, where radiation therapy is carefully designed and tailored to target cancerous cells while sparing healthy tissues. The CPT code range 77261-77299 provides a standardized framework for documenting and billing these procedures.

Key CPT codes include 77261 (radiation treatment planning, simple); 77262 (radiation treatment planning, complex); 77263 (radiation treatment planning, IMRT); and 77280 (radiation treatment planning, proton).

By accurately coding and documenting clinical treatment planning services, healthcare providers can ensure proper reimbursement and maintain the highest quality of care for their patients.

2. Medical Radiation Physics, Dosimetry, Treatment Devices, and Special Services for Radiation Treatment (CPT Code Range 77295-77370)

The CPT code range 77295-77370 in radiation oncology encompasses a wide array of medical radiation physics, dosimetry, treatment devices, and special services. These codes reflect the critical contributions of medical radiation physicists, dosimetrists, and specialized equipment in ensuring the accurate and safe delivery of radiation therapy.

• Medical radiation physics involves the application of physics principles and techniques to radiation therapy. CPT codes in this range reflect the services provided by medical radiation physicists to ensure the safe and accurate delivery of radiation treatment. These codes include radiation treatment machine quality assurance, linear accelerator beam data acquisition, and verification of radiation treatment plans.
• Dosimetry refers to the measurement and calculation of radiation doses delivered to patients during radiation therapy. CPT codes in this category cover a range of dosimetric services, such as computerized dose calculations, verification of dose distribution, and calculation of treatment machine settings. These codes also encompass the creation and evaluation of treatment plans using advanced techniques such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT).
• Treatment devices are essential components used in radiation therapy to accurately deliver radiation to the target area while minimizing exposure to healthy tissues. CPT codes within this range represent the provision and maintenance of treatment devices. Examples include codes for the fabrication and application of immobilization devices, such as custom radiation therapy immobilization masks, as well as codes for the construction and placement of compensators and bolus material.
• Special services in radiation treatment encompass a variety of procedures and techniques that support the overall delivery and management of radiation therapy. CPT codes in this range cover services such as the fusion of imaging modalities (CT, MRI, PET) for treatment planning and target delineation, the performance of radiation physics consultations, and special dosimetry procedures. These codes recognize the additional expertise and resources required for complex treatment scenarios and specialized patient needs.

3. Stereotactic Radiation Treatment Delivery (CPT Code Range 77371-77387)

Stereotactic radiation treatment delivery is a precise and advanced technique used in radiation oncology to deliver highly focused radiation to tumors with pinpoint accuracy. This treatment modality is particularly effective for small tumors and lesions in various parts of the body.

The CPT code range 77371-77387 encompasses a series of codes that describe the different aspects and components of stereotactic radiation treatment delivery.

The key CPT codes within this range are:

• 77371: Stereotactic radiation treatment delivery, single treatment area, single or multiple Fractions or sessions.
• 77372: Stereotactic radiation treatment delivery, single treatment area, four or more Fractions or sessions.
• 77373: Stereotactic radiation treatment delivery, multiple treatment areas, single or multiple Fractions or sessions.
• 77374: Stereotactic radiation treatment delivery, multiple treatment areas, four or more Fractions or sessions.
• 77385: Stereotactic body radiation therapy, treatment delivery, per fraction to one or more lesions, including image guidance, entire course not to exceed five fractions.
• 77386: Stereotactic body radiation therapy, treatment delivery, per fraction to one or more lesions, including image guidance, entire course not to exceed 10 fractions.

4. Radiation Treatment Delivery (CPT Code Range 77399-77417)

Radiation treatment delivery is a critical component of radiation oncology, which involves the administration of therapeutic radiation to target and eradicate cancer cells. The process of delivering radiation therapy requires precision and adherence to established protocols to maximize the therapeutic effect while minimizing damage to healthy tissues.

These codes reflect the complexity and techniques employed in delivering radiation therapy, ranging from simple to complex approaches.

Proper coding and billing for radiation treatment delivery also require a thorough understanding of other related codes and procedures. For example, radiation treatment planning (CPT codes 77261-77280) involves the development of a treatment plan, including target delineation and dose calculation.

Image guidance (CPT codes 77014, and 77417) involves the use of imaging techniques like CT scans to guide the accurate placement of radiation therapy fields. Brachytherapy (CPT codes 77750-77762) refers to the implantation of radioactive sources within or near the tumor site for localized treatment.

5. Neutron Beam Treatment Delivery (CPT Code Range 77423-77425)

Neutron beam therapy represents an advanced modality in radiation oncology, offering unique advantages in the treatment of certain cancers. The CPT code range 77423-77425 specifically addresses the various complexities involved in delivering neutron beam therapy.

These codes help facilitate accurate documentation, coding, and billing for the services provided, ensuring appropriate reimbursement for the healthcare providers delivering this specialized treatment.

Short descriptions of these codes are as follows:

• 77423: Neutron beam treatment delivery; simple
• 77424: Neutron beam treatment delivery; intermediate
• 77425: Neutron beam treatment delivery; complex

Kindly refer to the second part of this article for the remaining radiation oncology codes representing procedures like radiation treatment management; proton beam radiation treatment delivery; radiation hyperthermia treatment; clinical intracavitary radiation hyperthermia treatment; and clinical brachytherapy radiation treatment.

It is important to note that the information provided in this article serves as a general overview and does not substitute for the specific guidelines and regulations set forth by medical coding authorities.

Healthcare providers should consult the most up-to-date resources, such as official CPT coding guidelines and relevant billing regulations, for accurate and compliant coding and billing practices in radiation oncology.

The American Medical Association (AMA) periodically releases updates to the CPT code set, including guidelines and instructions for proper code usage. Regularly referring to these updates and consulting with coding experts can help ensure accurate coding and appropriate reimbursement for radiation oncology treatments.

About Medical Billers and Coders (MBC)

Medical Billers and Coders (MBC) is recognized as a leading radiation oncology billing company, providing comprehensive and specialized billing services tailored specifically to the unique needs of radiation oncology practices.

With our deep expertise and extensive knowledge of the ever-evolving medical billing and coding landscape, MBC ensures accurate and efficient revenue cycle management for radiation oncology providers.

Our team of skilled professionals is well-versed in the intricacies of radiation oncology coding, including the specific CPT codes, modifiers, and documentation requirements.

By partnering with MBC, radiation oncology practices can streamline their billing processes, maximize reimbursement, and focus on delivering exceptional patient care. To know more about our radiation oncology billing services, email us at: info@medicalbillersandcoders.com or call us at: 888-357-3226.

CPT® is a registered trademark of the American Medical Association

FAQs:

The post An Overview of Radiation Oncology Codes – Part 1 appeared first on Medical Billing and RCM Blogs.

MBC’s Oncology Billing Services

Our oncology billing services includes all activities ensuring that accurate and timely claims are submitted to insurance companies, and that payments are received in a timely manner. Following are some of the key services that a medical billing company can provide in the context of oncology billing and coding:

• Charge capture: This involves accurately recording the services provided to a patient, along with the corresponding charges, in order to ensure that all billable services are captured.
• Oncology coding: We have experienced oncology coders who can accurately assign the correct medical codes to each service provided, in accordance with the current coding guidelines and regulations.
• Claim submission: Once the charges have been captured and coded, we submit the claims to all insurance companies including Medicare, Medicaid, and all other commercial insurance companies.
• Payment posting: Once payments are received, we post them to the appropriate accounts in a timely and accurate manner.
• Denial management: In the event that a claim is denied, we investigate the reason for the denial and take appropriate action to resubmit the claim or appeal the decision.
• Follow-up on outstanding claims: Accounts receivable management services can help ensure that the practice follows up on outstanding claims in a timely manner. This can help speed up the payment process and reduce the amount of time it takes for the practice to receive payments.
• Reporting: We share detailed reports to oncologists, showing the status of each claim and providing valuable insights into the financial health of the practice.
• Provider credentialing: These services can help ensure that your oncology practice is in compliance with all relevant regulations and that your providers are properly qualified to provide care to patients.

In addition to these services, we also provide valuable guidance and support to oncologists in the area of compliance, helping to ensure that all billing and coding practices are in compliance with applicable laws and regulations.

Oncology Billing Best Practices by MBC

With our best practices, you can ensure accurate and timely payment for your oncology services, while improving patient satisfaction and reducing billing errors.

Here are MBC’s best practices for oncology billing:

• Staying up-to-date with coding guidelines: Oncology billing codes are constantly changing, so we constantly stay up-to-date with the latest coding guidelines to ensure accurate billing.
• Using the correct modifiers: Modifiers are used to indicate additional information about a service provided. It is important to use the correct modifiers when billing for oncology services to avoid denials and delays in payment.
• Verifying insurance coverage: Before providing any oncology services, we verify the patient’s insurance coverage to ensure that the planned services will be covered. This can help avoid issues with denied claims and ensure that the patient is not left with a large bill.
• Submitting claims in a timely manner: Oncology billing requires timely submission of claims to avoid payment delays and potential denials. We submit your claims as soon as possible to ensure timely payment.
• Monitoring payment trends: We keep track of payment trends and identify any potential issues early on. This can help to identify and address any billing or coding issues before they become major problems.

Why Choose Us?

There are several reasons why we are a leading oncology medical billing company, some of them are listed below:

• Increased revenue: MBC helps oncologists maximize their revenue by identifying and addressing areas of missed or under-coded charges. This can help providers avoid revenue losses and improve overall financial performance.
• Cost savings: Outsourcing oncology medical billing and coding to us can be more cost-effective for providers than maintaining an in-house billing and coding team. This is because the cost of hiring, training, and retaining skilled billers and coders can be high, especially for small and medium-sized practices.
• Reduced administrative burden: Choosing us as a billing partner can free up administrative staff to focus on other areas of the practice, such as patient care and practice management. This can lead to greater efficiency and productivity overall.
• Expertise and experience: Oncology medical billing and coding requires specialized knowledge and expertise that many healthcare providers may not have in-house. Outsourcing to MBC can ensure that the provider is receiving accurate, timely, and compliant billing and coding services.
• Compliance and regulatory requirements: Oncology billing and coding are subject to complex and ever-changing regulations and compliance requirements. An experienced billing and coding company like us, can help providers stay up-to-date with these requirements and avoid costly compliance errors.

To know more about how we can help your practice to grow business while staying compliant, email us at: info@medicalbillersandcoders.com or call us at: 888-357-3226.

FAQs

1. What services does Medical Billers and Coders (MBC) offer for oncology billing?

MBC provides comprehensive services, including charge capture, oncology coding, claim submission, payment posting, denial management, and accounts receivable management.

2. How does MBC ensure accurate coding for oncology practices?

Our experienced coders stay up-to-date with the latest coding guidelines and regulations to ensure accurate assignment of medical codes for all services provided.

3. Why is denial management important in oncology billing?

Effective denial management helps investigate the reasons for denied claims and ensures timely resubmission or appeals, minimizing revenue loss for the practice.

4. How can MBC help improve the financial health of an oncology practice?

By identifying missed charges and optimizing the billing process, MBC helps maximize revenue and improve overall financial performance for oncology practices.

5. What are the benefits of outsourcing oncology billing to MBC?

Outsourcing reduces administrative burdens, saves costs on in-house staffing, and provides specialized expertise in compliance and regulatory requirements, enhancing efficiency.

The post MBC: Leading Oncology Medical Billing Company appeared first on Medical Billing and RCM Blogs.

The Radiation Oncology Model aims to improve the quality of care for cancer patients receiving radiotherapy (RT) and move toward a simplified and predictable payment system. The RO Model tests whether prospective, site-neutral, modality agnostic, episode-based payments to physician group practices (PGPs), hospital outpatient departments (HOPD), and freestanding radiation therapy centers for RT episodes of care reduce Medicare expenditures while preserving or enhancing the quality of care for Medicare beneficiaries.

Delayed Implementation of Radiation Oncology Model

The alternative payment and care delivery model for cancer care aims to improve the quality of care for patients who receive radiotherapy and establish a predictive, simple payment system for providers who deliver those services. The model would do that through site-neutral bundled payments for a 90-day episode of radiotherapy and related services.

Providers in randomly selected areas would be required to participate, according to program rules. However, cancer care providers have questioned the model’s methodology, particularly its mandatory nature, since it was announced in 2019.

CMS believes that the Radiation Oncology Model would address long-standing concerns related to RT delivery and payment, including the lack of site neutrality for payments, incentives that encourage the volume of services over the value of services, and coding and payment challenges.

However, CMS decided to postpone the launch date given the legislative delays and persistent criticisms from industry stakeholders who have called for change. The agency also announced in the final rule that it would redefine the performance periods.

In Aug 2022, CMS made an announcement that it will propose a new start date for the Radiation Oncology Model via future rulemaking. Moving forward, CMS plans to propose a new start date “no less than 6 months prior to that proposed start date i.e., Jan 2023”.

Things to Know Prior to Implementation of Radiation Oncology Model

Radiation Oncology Model Design

The RO Model is a mandatory model that tests whether changing the way RT services are currently paid, via fee-for-service payments – to prospective, site-neutral, modality-agnostic, episode-based payments incentivizes physicians to deliver higher-value RT care. The design of the RO Model includes several key programmatic elements:

1. Alternative Payment

• Episode Payments: CMS makes prospective, episode-based (i.e., bundled) payments, based on a patient’s cancer diagnosis, that cover RT services furnished in a 90-day episode for the included cancer types meeting the included cancer type criteria described in the final rule;
• Site-neutrality: The Model uses site-neutral payment by establishing a common, adjusted national base payment amount for the episode, regardless of the setting where it is furnished;
• Professional and Technical Payment Components: Episode payments are split into professional and technical components to allow the current claims systems for the Physician Fee Schedule (PFS) and the Outpatient Prospective Payment System (OPPS) to be used to adjudicate RO Model claims and for consistency with existing business relationships.

Source: freepik.com

2. Linking Payment to Quality

The Model links payment to quality using reporting and performance on quality measures, clinical data reporting, and patient experience as factors when determining payment to RO participants.

The Model meets the requirements to qualify as an Advanced Alternative Payment Model (APM) and a Merit-Based Incentive Payment System (MIPS) APM under QPP starting in performance year (PY) 1.

RO Model Participants

RO Model participants can participate in the Model as Professional, Technical, or Dual participants. Some RO participants, like Physician Group Practices (PGPs), can be both Professional participants and Dual participants depending on the RT services they furnish during the RO episode.

• A Professional participant is a Medicare-enrolled PGP, identified by a single Taxpayer Identification Number (TIN) that furnishes only the Professional Component (PC) of RT services at either a freestanding radiation therapy center or a Hospital Outpatient Department (HOPD).
• A Technical participant is an HOPD or freestanding radiation therapy center, identified by a single CMS Certification Number (CCN) or TIN, which furnishes only the technical component (TC) of RT services during an RO episode.
• A Dual participant furnishes both the PC and TC of an RO episode for RT services through a freestanding radiation therapy center, identified by a single TIN.

RO Model Episode Pricing

RO participant-specific payment amounts are determined based on national base rates, trend factors, and adjustments for each participant’s case mix, historical experience, and geographic location. CMS further adjusts payment amounts by applying a discount factor.

The discount factor, or the set percentage by which CMS reduces an episode payment amount, reserves savings for Medicare and reduces beneficiary cost-sharing. RO participants can earn back all or some of the incorrect withhold based on the amount of incorrect payments during the previous PY.

RO participants have an opportunity to earn back a portion of the quality and patient experience withholds based on clinical data reporting, quality measure reporting and performance, and the beneficiary-reported Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Cancer Care Radiation Therapy Survey.

RO Participant Payment

RO episode payments are paid prospectively in the RO Model, meaning that half of the episode payment amount is paid when the RO episode is initiated, and the second half is paid when the RO episode ends.

Episode payments in the RO Model are split into a PC payment; which is meant to represent payment for the included RT services that may only be furnished by a physician; and a TC payment, which is meant to represent payment for the included RT services that are not furnished by a physician, including the provision of equipment, supplies, personnel, and costs related to RT services.

This division reflects the fact that RT professional and technical services are sometimes furnished by separate providers or suppliers.

Quality Measures

The RO Model includes four quality measures. These measures allow the RO Model to apply a pay-for-performance methodology that incorporates performance measurement with a focus on clinical care and beneficiary experience with the aim of capturing a reduction in expenditures and preserving or enhancing the quality of care for beneficiaries.

To do this, the Model withholds 2 percent of the PC, and 1 percent of the TC payments for each episode starting in PY3. RO participants have the ability to earn back a portion of the quality and patient experience withholds based on clinical data reporting, quality measure reporting, and performance, and the beneficiary reported CAHPS® Cancer Care Radiation Therapy Survey.

Medical Billers and Coders (MBC) is a leading medical billing company providing complete revenue cycle management services. Even though Radiation Oncology Model is not implemented yet, it’s always beneficial to know the basics of the RO model so that oncology practices can prepare themselves accordingly.

We referred CMS and other reliable sources to share basic information on Radiation Oncology Model for the purpose of provider education. In case you need assistance in oncology billing, email us at: info@medicalbillersandcoders.com or call us at: 888-357-3226.

Reference:

Radiation Oncology Model

CMS Delays Radiation Oncology Model With No New Start Date

FAQs

1. Why is medical billing in outpatient cancer care centers so complex?

Medical billing in outpatient cancer care is complex due to the variety of services like chemotherapy, radiation, and lab tests, which can be marked up far beyond Medicare reimbursements.

2. How do billing practices vary across cancer care centers?

Billing practices can vary significantly, with some cancer centers charging up to 4.1 times more than what Medicare reimburses, leading to high financial burdens for patients.

3. What is the issue with price transparency in cancer care billing?

The lack of price transparency in cancer care billing causes unexpected financial challenges for patients, as some centers engage in practices that inflate costs without clear justification.

4. How do medical billing companies help outpatient cancer care centers?

Medical billing companies with expertise in cancer care ensure accurate billing, compliance with regulations, and transparent practices, improving overall revenue cycle management and reducing costs for cancer care centers.

5. What is being done to protect patients from inflated cancer care costs?

To protect patients, some states are introducing laws to prevent unfair billing practices and protect patients from being held responsible for excessive charges that go beyond what the highest payer will reimburse.

The post Things to Know Prior to Implementation of Radiation Oncology Model appeared first on Medical Billing and RCM Blogs.

Chemotherapy Administration Coding Guidelines 2022

Reporting Initial Service Code

The CPT codes 96360, 96365, 96374, 96409, and 96413 describe ‘initial’ service codes. For a patient encounter, only 1 ‘initial’ service code may be reported unless it is medically reasonable and necessary that the drug or substance administrations occur at separate intravenous access sites. To report 2 different ‘initial’ service codes, you can use appropriate modifiers.

Using Correct POS

CPT codes 96360-96379, 96401-96425, and 96521-96523 are reportable by providers/suppliers for services performed in physicians’ offices. These drug administration services shall not be reported by providers/suppliers for services provided in a facility setting such as a hospital outpatient department or emergency department.

Drug administration services performed in an Ambulatory Surgical Center (ASC) related to Medicare-approved ASC payable procedures are not separately reportable by providers/suppliers. Hospital outpatient facilities may separately report drug administration services when appropriate.

The term ‘Physician’ in this article refers to M.D.s, D.O.s, and other practitioners who bill Medicare claims processing contractors for services payable on the MPFS (Medicare Physician Fee Schedule).

Billing CPT 99211

The drug and chemotherapy administration HCPCS/CPT codes 96360-96375, 96377 and 96401-96425 have been valued to include the work and practice expenses of CPT code 99211 (E&M service, office or other outpatient visit, established patient, level I).

Although CPT code 99211 is not reportable with chemotherapy and non-chemotherapy drug/substance administration HCPCS/CPT codes, other non-facility-based E&M CPT codes (e.g., 99202- 99205, 99212-99215) are separately reportable with modifier 25 if the physician provides a significant and separately identifiable E&M service. 

Since providers/suppliers shall not report drug administration services in a facility setting, a facility-based E&M CPT code (e.g., 99281- 99285) shall not be reported with a drug administration CPT code unless the drug administration service is performed at a separate patient encounter in a non-facility setting on the same date of service. In such situations, the E&M code should be reported with modifier 25.

Under the OPPS (Outpatient Prospective Payment System), hospitals may report drug administration services and facility-based E&M codes (e.g., 99281-99285, G0463) if the E&M service is significant and separately identifiable. In these situations, modifier 25 should be appended to the E&M code.

Inappropriate Use of CPT 96523

Flushing or irrigation of an implanted vascular access port or device prior to or subsequent to the administration of chemotherapeutic or non-chemotherapeutic drugs is integral to the drug administration service and is not separately reportable. Under these circumstances, do not report CPT code 96523.

Billing ‘refilling & maintenance of an implantable pump/reservoir for systemic drug delivery’

CPT code 96522 describes the refilling and maintenance of an implantable pump or reservoir for systemic drug delivery. The pump or reservoir must be capable of programmed release of a drug at a prescribed rate. CPT code 96522 shall not be reported for accessing a nonprogrammable implantable intravenous device for the provision of infusion(s) or chemotherapy administration. 

CPT code 96522 (Refilling and maintenance of implantable pump or reservoir for drug delivery, systemic (e.g., intravenous, intra-arterial) and CPT code 96521 (Refilling and maintenance of portable pump) shall not be reported with CPT code 96416 (Initiation of prolonged intravenous chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump) or CPT code 96425 (Chemotherapy administration, intra-arterial; infusion technique, initiation of prolonged infusion (more than 8 hours) requiring the use of a portable or implantable pump). CPT codes 96416 and 96425 include the initial filling and maintenance of a portable or implantable pump. CPT codes 96521 and 96522 are used to report subsequent refilling of the pump.

CPT codes 96521 and 96522 shall not be reported for accessing or flushing an indwelling peripherally-placed intravenous catheter port (external to skin), subcutaneous port, or nonprogrammable subcutaneous pump. Accessing and flushing these devices is an inherent service facilitating these infusion(s) and is not reported separately.

Billing CPT Code 96368

A concurrent intravenous infusion of an antiemetic or other non-chemotherapeutic drug with intravenous infusion of chemotherapeutic agents may be reported separately as CPT code 96368 (Concurrent intravenous infusion).

CPT code 96368 may be reported with a maximum of one unit of service per patient encounter regardless of the number of concurrently infused drugs or the length of time for the concurrent infusion(s). Hydration concurrent with chemotherapy is not separately reportable.

Medical Billers and Coders (MBC) is a leading medical billing company providing complete revenue cycle solutions. CPT® is a registered trademark of the American Medical Association (AMA).

We shared some of CPT codes and it’s guidelines for reference purpose only, for accurate use please refer to detailed code description. If you need assistance in Chemotherapy Administration Coding service, contact us at info@medicalbillersandcoders.com /  888-357-3226

FAQs:

The post Chemotherapy Administration Coding Guidelines 2022 appeared first on Medical Billing and RCM Blogs.

This final decision expands eligibility for people with Medicare to get lung cancer screening with LCDT by lowering the starting age for screening from 55 to 50 years and reducing the tobacco smoking history from at least 30 packs per year to at least 20 packs per year.

The only recommended screening test for lung cancer is LDCT, a unique computed tomography (CT) scan technique that combines special X-ray equipment with sophisticated computers to produce multiple, cross-sectional images of the inside of the body.

“Expanding coverage broadens access for lung cancer screening to at-risk populations,” said CMS Chief Medical Officer and Director of the Center for Clinical Standards and Quality, Dr. Lee Fleisher. 

The final decision also simplifies requirements for the counseling and shared decision-making visit and, based on public comments received on the proposed NCD and additional review, removes the requirement for the reading radiologist to document participation in continuing medical education, thereby reducing the administrative burden on providers.

CMS also added a requirement back to the NCD criteria for radiology imaging facilities to use a standardized lung nodule identification, classification, and reporting system.

Summary of Expanded Coverage

The Centers for Medicare & Medicaid Services (CMS) reconsidered the national coverage determination established in section 210.14 of the Medicare National Coverage Determinations manual and has determined that the evidence is sufficient to expand the eligibility criteria for Medicare beneficiaries receiving low dose computed tomography (LDCT) when the following criteria are met:

Beneficiary Eligibility Criteria

• Age 50 – 77 years;
• Asymptomatic (no signs or symptoms of lung cancer);
• Tobacco smoking history of at least 20 pack-years (one pack-year = smoking one pack per day for one year; 1 pack = 20 cigarettes);
• Current smoker or one who has quit smoking within the last 15 years; and
• Receive an order for lung cancer screening with LDCT.

Counseling and Shared Decision-Making Visit

Before the beneficiary’s first lung cancer LDCT screening, the beneficiary must receive counseling and a shared decision-making visit that meets all of the following criteria, and is appropriately documented in the beneficiary’s medical records:

• Determination of beneficiary eligibility;
• Shared decision-making, including the use of one or more decision aids;
• Counseling on the importance of adherence to annual lung cancer LDCT screening, the impact of comorbidities and ability or willingness to undergo diagnosis and treatment; and
• Counseling on the importance of maintaining cigarette smoking abstinence if former smoker; or the importance of smoking cessation if current smoker and, appropriate, furnishing of information about tobacco cessation interventions.

Our team works behind the scenes to help you understand the insurance and oncology billing process so you can focus on your Treatment.

Reading Lung Cancer Radiologist Eligibility Criteria

For purposes of Medicare coverage of lung cancer screening with LDCT, the reading radiologist must have board certification or board eligibility with the American Board of Radiology or equivalent organization.

Lung Cancer Radiology Imaging Facility Eligibility Criteria

For purposes of Medicare coverage, lung cancer screening with LDCT must be furnished in a radiology imaging facility that utilizes a standardized lung nodule identification, classification, and reporting system.

The above policy simplifies requirements for the counseling and shared decision-making visit, removes the restriction that it must be furnished by a physician or non-physician practitioner, reduces the eligibility criteria for the reading radiologist, and reduces the radiology imaging facility eligibility criteria (including removes the requirement that facilities participate in a registry). You can find a detailed decision and their background on the CMS website. 

Medical Billers and Coders (MBC) is a leading medical billing company providing complete revenue cycle management services. For provider education, we share the latest billing news and updated billing guidelines in form of articles.

For the latest medical billing and coding resources, visit our blog page. If you need any help in medical billing and coding for your practice, contact us at info@medicalbillersandcoders.com/ 888-357-3226

FAQs

1. What is the purpose of the CMS’s decision on lung cancer screening?

The CMS expanded coverage for lung cancer screening using LDCT to help detect non-small cell lung cancer early, improving health outcomes by including more at-risk individuals.

2. Who is eligible for Medicare coverage of lung cancer screening?

Medicare beneficiaries aged 50-77 with a smoking history of at least 20 pack-years, who are asymptomatic and either current or former smokers, are eligible for LDCT screening.

3. What is the required counseling for lung cancer screening?

Before the screening, patients must receive counseling that includes decision-making on eligibility, the importance of annual screening, and smoking cessation or abstinence advice.

4. What are the requirements for radiologists and facilities performing lung cancer screenings?

Radiologists must be board-certified by the American Board of Radiology or an equivalent, and facilities must use a standardized system for lung nodule identification and reporting.

5. How does CMS’s new policy affect healthcare providers?

The new policy simplifies requirements for counseling, shared decision-making, radiologist eligibility, and imaging facility standards, reducing administrative burdens for providers.

The post Expanded Coverage of Lung Cancer Screening with LDCT appeared first on Medical Billing and RCM Blogs.

Annual changes in medical coding, payer-specific billing guidelines, government program rules, and changed regulations make oncology medical billing challenges. As most of the time is utilized inpatient care, staying on top of all coding and billing updates and payer-specific guidelines is next to impossible.

There is a solution: outsourcing your oncology medical billing.  A high rise is observed in outsourcing oncology medical billing services by providers and medical practices. The top reason physicians and clinics are outsourcing is to cut operational costs.

Other reasons include increasing healthcare costs, federal mandate to implement electronic health records, obligatory implementation of the complex ICD-10 coding system, and maintain reimbursement levels.

Outsourcing your oncology medical billing services can increase revenue while allowing medical professionals to get back to focusing on patient care. 

Better Control

Many practice owners fear that they will lose control over the revenue cycle if they outsource their medical billing operations. In reality, you are in more control than ever before. The outsourced team takes care of your time-consuming tasks and deals with troublesome procedures to reduce your stress or headache.

Your outsourced billing team will take care of the entire responsibility of oncology medical billing and provide you breathing room to review daily/weekly/monthly reports. You can get a clear picture of your practice’s financial health by reviewing these reports.

You will be assigned an account manager who will deal with all the queries formed after the comparison of monthly or yearly reports. You can discuss issues like payer reimbursement problems and charge entry errors, etc, and rectify the problematic issues in advance.

Streamline Oncology Billing

Managing in-house billing staff offer challenges like employee turnover, unplanned leaves, constant training, and staff administration. With in-house billing, you are highly dependent on a few personnel and if they leave your organization, it directly affects day-to-day billing operations like charge entry, eligibility verification, and accounts receivables management.

When you outsource oncology medical billing services, you get access to a whole team of trained individuals that ensure your medical claims are processed accurately. Moreover, you can get the advantage of a vast knowledge base as industry experts handle your tasks on your behalf and save your business from revenue loss. 

Increased Revenue

Oncology billing involves more detailed, higher-cost services, so losing a single claim can be a large loss of revenue. Your outsourced billing team has the experience to recognize any potential problems and get them rectified swiftly.

Oncology billing experts utilize effective procedures and policies to minimize the time required to receive insurance reimbursements. They ensure that medical claims are submitted correctly and ensure there are no claim rejections or denials.

You save a lot of money by outsourcing as outsourcing company only charge a percentage of the revenue that they collect. This amount is almost half of your in-house billing staff’s salary, insurance, and other benefits costs. By outsourcing, you are decreasing your operational costs and increasing your practice revenue.

In oncology medical billing, the basic assumption is that you can do better on your own. But in reality, you cannot handle cumbersome billing and coding processes and provide quality care services. It might be hectic for you to go this route and manually manage tasks.

Outsourcing ensures you can carve out more time to stay up-to-date about the carrier’s regulations. You are able to keep a strict follow-up on medical claims and drive maximum revenue efficiently.

Medical Billers and Coders (MBC) is a leading medical billing company in the United States. Our dedicated oncology billing department handles all your needs of medical billing and coding. When you outsource your oncology medical billing, you gain peace of mind.

To know more about our oncology medical billing and coding services, email us at: info@medicalbillersandcoders.com or call us at: 888-357-3226.

FAQs

1. Why should I consider outsourcing oncology medical billing?

Outsourcing reduces the administrative burden, helping you focus on patient care and improving revenue by managing complex billing tasks effectively.

2. Will I lose control over my billing if I outsource?

No, you’ll maintain control through regular, detailed reports and can discuss issues directly with your dedicated account manager.

3. How does outsourcing help increase revenue for my oncology practice?

With industry expertise, the outsourced team ensures accurate claims processing and faster reimbursements, helping prevent revenue loss from claim rejections.

4. What specific tasks does an outsourced oncology billing team handle?

They manage charge entry, eligibility verification, accounts receivables, and follow-ups, ensuring every aspect of billing is accurately completed.

5. Is outsourcing more cost-effective than in-house billing?

Yes, outsourcing typically costs less than hiring in-house staff, as you pay only a percentage of collected revenue, reducing overall operational costs.

The post Benefits of Outsourcing Oncology Medical Billing appeared first on Medical Billing and RCM Blogs.